Predictive factors of ovarian response to GnRH antagonist stimulation protocol: AMH and age are potential candidates

被引：0
|
作者：
Mohammed M. Laqqan
Maged M. Yassin
机构：
[1] Islamic University,Department of Medical Laboratory Sciences, Faculty of Health Sciences
[2] Saarland University “Graduate”,Department of Gynecology & Obstetrics, Faculty of Medicine
[3] Al-Azhar University,Department of Physiology, Faculty of Medicine
来源：
Middle East Fertility Society Journal | / 26卷
关键词：
Age; AMH; GnRH antagonist; Infertility; Oocyte; Ovarian response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: A meta-analysis
    Qin, Ying
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2021, 50 (08)
  • [42] GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels
    Orvieto, Raoul
    Nahum, Ravit
    Meltzer, Simion
    Liberty, Gadi
    Anteby, Eyal Y.
    Zohav, Efraim
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (09) : 843 - 845
  • [43] What is the value of anti-Mullerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?
    Knez, Jure
    Kovacic, Borut
    Medved, Maruska
    Vlaisavljevic, Veljko
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
  • [44] Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET
    E. Tsakos
    A. Tolikas
    Angelos Daniilidis
    B. Asimakopoulos
    Archives of Gynecology and Obstetrics, 2014, 290 : 1249 - 1253
  • [45] GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study
    Huang, Ming-Chao
    Tzeng, Shu-Ling
    Lee, Chun-, I
    Chen, Hsiu-Hui
    Huang, Chun-Chia
    Lee, Tsung-Hsien
    Lee, Maw-Sheng
    PLOS ONE, 2018, 13 (11):
  • [46] Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist
    Marci, Roberto
    Lisi, Franco
    Soave, Ilaria
    Lo Monte, Giuseppe
    Patella, Alfredo
    Caserta, Donatella
    Moscarini, Massimo
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (10) : 792 - 795
  • [47] Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation
    Zhao, Weie
    Sun, Peng
    Li, Tingting
    Li, Yongfang
    Liang, Xiaoyan
    Li, Jingjie
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 163 (02) : 645 - 650
  • [48] The effects of letrozole+GnRH antagonist versus mere GNRH antagonist during IVF in patients with poor ovarian response
    Mehrabian, Ferdos
    Ataie-Khorasgani, Mahnaz
    Naghshineh, Elham
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (06): : 2010 - 2015
  • [49] The use of Recombinant Luteinizing Hormone in Addition to Recombinant Follicle-stimulating Hormone in Ovarian Stimulation with the GnRH-antagonist Protocol
    Baruffi, Ricardo L. R.
    Mauri, Ana L.
    Petersen, Claudia G.
    Felipe, Valeria
    Martins, Anice M. C.
    Cornicelli, Joao
    Cavagna, Mario
    Oliveira, Joao B. A.
    Franco, Jose G., Jr.
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2006, 10 (04): : 9 - 16
  • [50] Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol
    Yang, Lanlin
    Luo, Keli
    Lu, Guangxiu
    Lin, Ge
    Gong, Fei
    REPRODUCTIVE BIOMEDICINE ONLINE, 2022, 45 (04) : 721 - 726
12345